A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids

Buyse G.; Mayer O.; Donisa-Dreghici R.; Couttet F.; Wolff J.; Coppard N.

首页> 外文期刊>Neuromuscular disorders: NMD >A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids

【24h】

A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids

机译：一项III期双盲，随机，安慰剂对照研究（SIDEROS）评估了艾地苯醌在减缓接受糖皮质激素类固醇的杜氏肌营养不良患者的呼吸功能丧失速率方面的功效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuromuscular disorders: NMD》 |2016年第2期|共1页
作者
Buyse G.; Mayer O.; Donisa-Dreghici R.; Couttet F.; Wolff J.; Coppard N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献

1. A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids [J] . Buyse G., Mayer O., Donisa-Dreghici R., Neuromuscular disorders: NMD . 2016,第Suppla2期

机译：一项III期双盲，随机，安慰剂对照研究（SIDEROS）评估了艾地苯醌在减缓接受糖皮质激素类固醇的杜氏肌营养不良患者的呼吸功能丧失速率方面的功效
2. Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial. [J] . Buyse GM, Goemans N, van den Hauwe M, Neuromuscular disorders: NMD . 2011,第6期

机译：艾地苯醌是一种针对杜氏肌营养不良症的新型治疗方法：一项为期12个月的双盲，随机安慰剂对照试验。
3. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy [J] . BuyseG.M., GoemansN., VanDenHauweM., Pediatric Pulmonology . 2013,第9期

机译：糖皮质激素和艾地苯醌对杜氏肌营养不良患者呼吸功能的影响
4. Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy [O] . Oscar H. Mayer, Mika Leinonen, Christian Rummey, -1

机译：艾地苯醌能使呼吸道功能保持在具有临床意义的杜兴氏肌营养不良患者强迫肺活量（FVC）阈值以上
5. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial [O] . Buyse Gunnar M, Voit Thomas, Schara Ulrike, 2015

机译：艾地苯醌对未使用糖皮质激素（DELOS）的杜兴氏肌营养不良患者呼吸功能的功效：一项双盲，随机安慰剂对照的3期试验

A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids

著录项

相似文献

相关主题

期刊订阅